Zimi Raises A$1.4 Million with Director Participation in Placement

Placement Details and Structure

Zimi Limited (ASX:ZMM) has secured firm commitments for a placement raising approximately A$1.4 million through the issue of around 364 million new shares at a discounted price of A$0.004 each. The placement is split into two tranches: the first tranche of 185 million shares will be issued under existing capacity rules, while the second tranche of 179.5 million shares requires shareholder approval and includes the participation of non-executive director Simon Gerard, who intends to subscribe for 38.3 million shares valued at just over A$153,000.

Incentives and Discounted Pricing

Alongside the shares, placement participants will receive one free-attaching unlisted option for every two shares subscribed, exercisable at A$0.006 and expiring in March 2029, subject to shareholder approval. This sweetener comes as the shares are offered at a 20% discount to the last traded price of A$0.005 on 28 April 2026 and a 23% discount to the 15-day volume weighted average price (VWAP) of A$0.0051. Cerberus Advisory is leading the placement and will receive 37 million options on similar terms, pending shareholder approval.

Use of Proceeds and Operational Context

The funds raised will support working capital needs, manufacturing costs tied to sales orders, and investment in new sales initiatives. This capital injection follows a period of notable operational progress for Zimi, including expanded manufacturing capacity aligned with its partnership with Zencontrol and growing distribution through key Australian partners such as Trader and Beacon Lighting. CEO Jordan Tentori emphasised the company’s focus on sales delivery and growth into new market channels, positioning Zimi for its next phase of expansion.

Capital Structure and Market Impact

Post-placement, Zimi’s issued shares will increase from approximately 756 million to 1.12 billion, lifting the company’s market capitalisation at the placement price to about A$4.48 million from A$3.02 million. While the raise dilutes existing shareholders, director participation signals board confidence in the company’s prospects. This move follows Zimi’s recent largest project order announcement, which highlighted growing revenue and operational efficiencies, and builds on its earlier manufacturing relocation completion that set the stage for scaling production.

Next Steps and Shareholder Approval

The second tranche of the placement, including the director’s participation and the issue of options, awaits shareholder approval at a general meeting expected in mid to late June 2026. Settlement and allotment of tranche one shares are scheduled for early May, with tranche two following shareholder consent. Investors will be watching closely how the market absorbs the dilution and whether the capital injection translates into accelerated sales growth and operational momentum.